Maintenance of tolerance by regulation of anti-myeloperoxidase B cells

Journal of the American Society of Nephrology

Volumn 19, Issue 9, 2008, Pages 1763-1773

  Bunch, Donna O ^a   Silver, Jonathan S ^a   Majure, Melanie C ^a   Sullivan, Pamela ^a   Alcorta, David A ^a   Chin, Hyunsook ^a   Hogan, Susan L ^a   Lindstrom, Yoshi I ^a   Clarke, Stephen H ^a   Falk, Ronald J ^a   Nachman, Patrick H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MYELOBLASTIN; MYELOPEROXIDASE; ANTIBODY; IMMUNOGLOBULIN KAPPA CHAIN; PEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL POPULATION; GENE EXPRESSION; HEAVY CHAIN; IMMUNOLOGICAL TOLERANCE; LIGHT CHAIN; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SMALL VESSEL VASCULITIS; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; APOPTOSIS; AUTOIMMUNE DISEASE; BONE MARROW CELL; CELL COUNT; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; SPLEEN;

ANIMALS; ANTIBODIES; APOPTOSIS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; BONE MARROW CELLS; CELL COUNT; IMMUNE TOLERANCE; IMMUNOGLOBULIN KAPPA-CHAINS; MICE; MICE, TRANSGENIC; PEROXIDASE; SPLEEN;

EID: 54749088034     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007030382     Document Type: Article

References (47)

1. Jennette JC, Falk RJ: Small-vessel vasculitis. N Engl J Med 337: 1512-1523, 1997
2. Yang JJ, Tuttle RH, Hogan SL, Taylor JG, Phillips BD, Falk RJ, Jennette JC: Target antigens for anti-neutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils. Clin Exp Immunol 121: 165-172, 2000
3. Kettritz R, Choi M, Butt W, Rane M, Rolle S, Luft FC, Klein JB: Phosphatidylinositol 3-kinase controls antineutrophil cytoplasmic antibodies-induced respiratory burst in human neutrophils. J Am Soc Nephrol 13: 1740-1749, 2002
4. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110: 955-963, 2002
5. Kobayashi K, Shibata T, Sugisaki T: Aggravation of rat nephrotoxic serum nephritis by anti-myeloperoxidase antibodies. Kidney Int 47: 454-463, 1995
6. Heeringa P, Brouwer E, Klok PA, Huitema MG, van den BJ, Weening JJ, Kallenberg CG: Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat. Am J Pathol 149: 1695-1706, 1996
7. Xiao H, Heeringa P, Liu Z, Huugen D, Hu P, Maeda N, Falk RJ, Jennette JC: The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 167: 39-45, 2005
8. Schreiber A, Xiao H, Falk RJ, Jennette JC: Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies. J Am Soc Nephrol 17: 3355-3364, 2006
9. Nachman PH, Reisner HM, Yang JJ, Jennette JC, Falk RJ: Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis. Lab Invest 74: 519-527, 1996
10. Kinjoh K, Good RA, Nenmoto K, Ralk RJ, Jennette JC: SCG/Kj mice develop crescentic glomerulonephritis (CGN), vasculitis and MPO-specific P-ANCA. Clin Exp Immunol 101: 53, 1995
11. Neumann I, Birck R, Newman M, Schnulle P, Kriz W, Nemoto K, Yard B, Waldherr R, Van Der Woude FJ: SCG/Kinjoh mice: A model of ANCA-associated crescentic glomerulonephritis with immune deposits. Kidney Int 64: 140-148, 2003
12. Jethwa HS, Clarke SH, Itoh-Lindstrom Y, Falk RJ, Jennette JC, Nachman PH: Restriction in V kappa gene use and antigen selection in anti-myeloperoxidase response in mice. J Immunol 165: 3890-3897, 2000
13. Loder F, Mutschler B, Ray RJ, Paige CJ, Sideras P, Torres R, Lamers MC, Carsetti R: B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 190: 75-89, 1999
14. Nemazee DA, Burki K: Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337: 562-566, 1989
15. Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA, Pritchard-Briscoe H, Wotherspoon JS, Loblay RH, Raphael K: Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334: 676-682, 1988
16. Tiegs SL, Russell DM, Nemazee D: Receptor editing in self-reactive bone marrow B cells. J Exp Med 177: 1009-1020, 1993
17. Radic MZ, Erikson J, Litwin S, Weigert M: B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med 177: 1165-1173, 1993
18. Chen C, Nagy Z, Radic MZ, Hardy RR, Huszar D, Camper SA, Weigert M: The site and stage of anti-DNA B-cell deletion. Nature 373: 252-255, 1995
19. Halverson R, Torres RM, Pelanda R: Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat Immunol 5: 645-650, 2004
20. Hippen KL, Schram BR, Tze LE, Pape KA, Jenkins MK, Behrens TW: In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance. J Immunol 175: 909-916, 2005
21. Gauld SB, Merrell KT, Cambier JC: Silencing of autoreactive B cells by anergy: A fresh perspective. Curr Opin Immunol 18: 292-297, 2006
22. Cambier JC, Gauld SB, Merrell KT, Vilen BJ: B-cell anergy: From transgenic models to naturally occurring anergic B cells? Nat Rev Immunol 7: 633-643, 2007
23. Vittecoq O, Brard F, Jovelin F, Le Loet X, Tron F, Gilbert D: IgM anti-myeloperoxidase antibody-secreting lymphocytes are present in the peripheral repertoire of lupus mice but rarely differentiate into IgG-producing cells. Clin Exp Immunol 118: 122-130, 1999
24. Okamoto M, Murakami M, Shimizu A, Ozaki S, Tsubata T, Kumagai S, Honjo T: A transgenic model of autoimmune hemolytic anemia. J Exp Med 175: 71-79, 1992
25. Chipuk JE, Green DR: Do inducers of apoptosis trigger caspase-independent cell death? Nat Rev Mol Cell Biol 6: 268-275, 2005
26. Russell DM, Dembic Z, Morahan G, Miller JF, Burki K, Nemazee D: Peripheral deletion of self-reactive B cells. Nature 354: 308-311, 1991
27. Murakami M, Tsubata T, Okamoto M, Shimizu A, Kumagai S, Imura H, Honjo T: Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 357: 77-80, 1992
28. Li Y, Li H, Weigert M: Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med 195: 181-188, 2002
29. Chen X, Martin F, Forbush KA, Perlmutter RM, Kearney JF: Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol 9: 27-41, 1997
30. Casola S, Otipoby KL, Alimzhanov M, Humme S, Uyttersprot N, Kutok JL, Carroll MC, Rajewsky K: B cell receptor signal strength determines B cell fate. Nat Immunol 5: 317-327, 2004
31. Murakami M, Honjo T: Anti-red blood cell autoantibody transgenic mice: Murine model of autoimmune hemolytic anemia. Semin Immunol 8: 3-9, 1996
32. Wang H, Clarke SH: Positive selection focuses the VH12 B-cell repertoire towards a single B1 specificity with survival function. Immunol Rev 197: 51-59, 2004
33. Berland R, Wortis HH: Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 20: 253-300, 2002
34. Lam KP, Rajewsky K: B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J Exp Med 190: 471-477, 1999
35. Watanabe N, Nisitani S, Ikuta K, Suzuki M, Chiba T, Honjo T: Expression levels of B cell surface immunoglobulin regulate efficiency of allelic exclusion and size of autoreactive B-1 cell compartment. J Exp Med 190: 461-469, 1999
36. Pogue SL, Goodnow CC: Gene dose-dependent maturation and receptor editing of B cells expressing immunoglobulin (Ig)G1 or IgM/IgG1 tail antigen receptors. J Exp Med 191: 1031-1044, 2000
37. Feuk L, Carson AR, Scherer SW: Structural variation in the human genome. Nat Rev Genet 7: 85-97, 2006
38. Nadeau JH, Lee C: Genetics: Copies count. Nature 439: 798-799, 2006
39. Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, Mangion J, Roberton-Lowe C, Marshall AJ, Petretto E, Hodges MD, Bhangal G, Patel SG, Sheehan-Rooney K, Duda M, Cook PR, Evans DJ, Domin J, Flint J, Boyle JJ, Pusey CD, Cook HT: Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439: 851-855, 2006
40. Pillai S, Cariappa A, Moran ST: Marginal zone B cells. Annu Rev Immunol 23: 161-196, 2005
41. Hardy RR: B-1 B cells: development, selection, natural autoantibody and leukemia. Curr Opin Immunol 18: 547-555, 2006
42. Wloch MK: The Role of Somatic Mutation in the Immune Response to the Sb Site of Influenza Hemagglutinin [Doctoral thesis], Chapel Hill, University of North Carolina at Chapel Hill, 1993, pp 58-86
43. Retter MW, Cohen PL, Eisenberg RA, Clarke SH: Both Sm and DNA are selecting antigens in the anti-Sm B cell response in autoimmune MRL/lpr mice. J Immunol 156: 1296-1306, 1996
44. Jethwa HS, Nachman PH, Falk RJ, Jennette JC: False-positive myeloperoxidase binding activity due to DNA/anti-DNA antibody complexes: A source for analytical error in serologic evaluation of antineutrophil cytoplasmic autoantibodies. Clin Exp Immunol 121: 544-550, 2000
45. Erdbrugger U, Hellmark T, Bunch DO, Alcorta DA, Jennette JC, Falk RJ, Nachman PH: Mapping of myeloperoxidase epitopes recognized by MPO-ANCA using human-mouse MPO chimers. Kidney Int 69: 1799-1805, 2006
46. Santulli-Marotto S, Retter MW, Gee R, Mamula MJ, Clarke SH: Autoreactive B cell regulation: Peripheral induction of developmental arrest by lupus-associated autoantigens. Immunity 8: 209-219, 1998
47. Kilmon MA, Wagner NJ, Garland AL, Lin L, Aviszus K, Wysocki LJ, Vilen BJ: Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6. Blood 110: 1595-1602, 2007